| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.024 | 0.9 |